Pharma channel feed

No­vo surges on up­beat Q4 re­view and a move to pro­duce We­govy in-house. But charge of in­sulin price ma­nip­u­la­tion lingers

4 years ago

GSK grabs $1.25B cash and a cut of Gilead­'s megablock­buster Bik­tarvy sales as HIV ri­vals set­tle patent suit

4 years ago

New buy­ers lin­ing up bids for No­var­tis' gi­ant gener­ics arm

4 years ago

Af­ter deal shield­ing Sack­lers from fur­ther lit­i­ga­tion over­turned, fam­i­ly mem­bers to pour more mon­ey in­to set­tle­ment

4 years ago

Pfiz­er raids Roche ex­ec­u­tive com­mit­tee for new drug de­vel­op­ment chief — and Schwan plucks his re­place­ment from the board

4 years ago
People

Bio­gen leaps in­to a show­down be­tween Roche and Re­gen­eron, bet­ting on a po­ten­tial new fran­chise play­er

4 years ago
FDA+

Mar­ket­ingRx Q&A: Evofem CEO Saun­dra Pel­leti­er on frank con­ver­sa­tions and dis­rupt­ing the con­tra­cep­tion mar­ket

4 years ago
Marketing

Mar­ket­ingRx roundup: Ho­log­ic goes to the Su­per Bowl with Mary J. Blige; Hori­zon bows Graves’ dis­ease TV ad

4 years ago
Marketing

FDA ex­pands la­bel for Vi­iV's Cabe­nu­va to cov­er bi-month­ly ad­min­is­tra­tion HIV treat­ment

4 years ago

Weight loss spin­out Gele­sis ditch­es pro­mo­tion­al staff af­ter SPAC fail — re­port

4 years ago
Marketing

Ho­log­ic plans Su­per Bowl ad with Mary J. Blige to show women ‘Re­al Love’ means health check­ups

4 years ago
Marketing

As­traZeneca adds chron­ic kid­ney dis­ease TV ad to Farx­i­ga port­fo­lio

4 years ago
Marketing

In pledg­ing to vote for Rob Califf, Eliz­a­beth War­ren takes a swing at the FDA-in­dus­try re­volv­ing door

4 years ago
FDA+

Mark Cuban's new cost-plus-15% gener­ic drug com­pa­ny is re­al­ly a com­pound­ing phar­ma­cy

4 years ago
Manufacturing

The FDA ap­proves Mod­er­na's rev­o­lu­tion­ary new Covid-19 vac­cine. What took so long?

4 years ago
Bioregnum
FDA+

Which FDA guid­ance doc­u­ments are com­ing for drug­mak­ers in 2022? Agency un­veils new lists

4 years ago
FDA+

Mar­ket­ingRx Matchup: Glax­o­SmithK­line, As­traZeneca asth­ma TV ads face off in con­sumer rat­ings

4 years ago
Marketing

Chi­nese agency says sus­pects ar­rest­ed in As­traZeneca in­sur­ance fraud probe

4 years ago

FDA clears Roche’s bis­pe­cif­ic Eylea con­tender, but can it com­pete with the Re­gen­eron block­buster?

4 years ago
FDA+

Cy­ber­se­cu­ri­ty ex­perts warn bio­phar­ma in­dus­try is not pre­pared for the next big at­tack: 'We are thor­ough­ly f****d'

4 years ago
R&D

Mer­ck en­lists HPV-re­lat­ed can­cer sur­vivors and physi­cians in so­cial and dig­i­tal ‘Sto­ry’ cam­paign

4 years ago
Marketing

Re­gen­eron and Sanofi pull Lib­tayo app in cer­vi­cal can­cer, cit­ing post-mar­ket study dis­agree­ment with FDA

4 years ago
FDA+

WHO of­fi­cial un­der fire af­ter al­le­ga­tions of racism, leak­ing sen­si­tive da­ta — re­port

4 years ago

Am­gen, Re­gen­eron and oth­ers seek more de­tail from FDA on re­al-world da­ta plans

4 years ago
FDA+
First page Previous page 225226227228229230231 Next page Last page
A service from the Financial Times